| abstract |
The present invention relates to formula (I) Wherein one of A 1 , A 2 or A 3 is N, the rest are independently selected from CH or N, ring B is a condensed 5- or 6-membered carbocyclic or heterocyclic ring, as defined herein Optionally substituted as R 1 , R 2 , R 3 , R 4 and n are as defined herein) The compounds of the present invention are inhibitors of EphB4 or EphA2 and thus may be useful in pharmaceutical compositions for the treatment of conditions such as cancer. |